Cite
HARVARD Citation
Papadavid, E. et al. (n.d.). Real life data on advanced cutaneous T cell lymphoma patients treated with brentuximab vedotin: results from a multicenter European EORTC study. European journal of cancer. pp. S34-S35. [Online].